drugset / Trial / NCT01256853
Modified Vaccinia Ankara (MVA) Vaccine Study
NaSingle-groupOpen-labelTreatment
Summary
This is a phase I, dose escalation trial of MVA-EBNA1/LMP2 vaccine across a pre-defined range of doses in patients in remission having had an EBV+ nasopharyngeal carcinoma (NPC).
Timeline
- Start
- 2006-09
- Primary completion
- 2010-09
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MVA Vaccine | Vaccine | 5e+07 unknown | Intramuscular |
| Subject | MVA Vaccine | Vaccine | 1e+08 unknown | Intramuscular |
| Subject | MVA Vaccine | Vaccine | 2e+08 unknown | Intramuscular |
| Subject | MVA Vaccine | Vaccine | 3.3e+08 unknown | Intramuscular |
| Subject | MVA Vaccine | Vaccine | 5e+08 unknown | Intramuscular |